STOCK TITAN

NEXGEL Acquires International Beauty Brand, Silly George

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Positive)
Rhea-AI Summary

NEXGEL (NASDAQ: NXGL) has acquired Silly George, an international beauty brand specializing in eye and eyelash products, for $400,000 in cash, $200,000 in NEXGEL common stock, and a 4-year net profit earn out. Silly George, with a revenue run rate of approximately $2 million, offers a range of products including non-toxic eyelash extensions and lash serums, predominantly sold direct-to-consumer and on Amazon in the U.S., U.K., Australia, and the Netherlands. The acquisition is expected to add $2 million in annual revenue and provides operational synergies through marketing optimization and expense overlap. Silly George's strong social media presence and customer database will also offer cross-selling opportunities for NEXGEL's portfolio. CEO Adam Levy highlighted the acquisition as a strategic move towards profitability, leveraging synergies and expanding their product portfolio in the health and beauty sector.

Positive
  • Addition of approximately $2 million in annualized revenue.
  • Operational synergies expected to drive operating margin expansion.
  • Access to Silly George's existing customer base and social media following, boosting cross-selling opportunities.
  • Inventory provided at cost and paid after the sale, minimizing upfront costs.
  • Strategic expansion into the international market with products sold in the U.S., U.K., Australia, and the Netherlands.
Negative
  • Acquisition cost includes $400,000 in cash, which could impact liquidity.
  • Dilution of existing shareholders due to issuance of $200,000 in common stock.
  • Reliance on the successful integration of Silly George to realize operational synergies.
  • 4-year net profit earn out may pose long-term financial obligations.

Insights

The acquisition of Silly George by NEXGEL adds approximately $2 million to its annualized revenue. This acquisition cost involves $400,000 in cash, $200,000 in common stock and a 4-year net profit earn-out. While the financial outlay is relatively modest compared to the added revenue, several factors must be considered: operational synergies, cross-selling opportunities and potential for margin expansion. The acquisition seems aimed at boosting profitability through immediate synergies and leveraging Silly George's existing customer base. However, the impact on NEXGEL's bottom line will depend on effective integration and realization of promised synergies. Investors should monitor NEXGEL's future earnings reports closely to see if the operational efficiencies and revenue enhancements materialize as projected.

Silly George's established presence in the international market, including the United Kingdom, Australia and the Netherlands, provides NEXGEL the opportunity to expand its geographical footprint. The beauty segment targeted by Silly George, particularly in eyelash products, is a high-growth area driven by consumer demand for non-toxic, easy-to-use beauty enhancements. The brand's strong social media following and substantial customer email list of over 254,000 provide a ready audience for NEXGEL to tap into. This move could enhance brand visibility and market penetration for NEXGEL's existing and new products. However, the success of this acquisition will hinge on NEXGEL's ability to effectively market and cross-sell its products to this new consumer base while maintaining the quality and reputation of Silly George's brand.

The innovative aspect of Silly George's product line, particularly the Pop-On Lashes technology, aligns well with NEXGEL's focus on high-water-content hydrogel products. This technology offers non-toxic and long-wearing alternatives to traditional eyelash extensions, appealing to consumers looking for safer beauty options. From a technical standpoint, integrating Silly George's product innovation with NEXGEL's existing technological capabilities could drive further advancements and new product development in the beauty and healthcare sectors. However, the challenge will be in scaling production and maintaining quality during the transition period.

Acquisition further expands NEXGEL Health, Wellness, and Beauty consumer product portfolio

Silly George is on a revenue run rate of approximately $2 million

LANGHORNE, Pa., May 16, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced the acquisition of Silly George, an international beauty company with specialty in eye and eyelash consumer products and a revenue run rate of approximately $2 million.

Silly George offers its loyal consumer base a full product line of eye and eyelash products including hassle-free alternatives to harmful glue-on eyelashes such lash extensions, lash serum and accessories. Silly George is predominately sold DTC and on Amazon not only in the United States, but internationally in the United Kingdom, Australia and the Netherlands as well. The Company recently launched a new line of Pop-On Lashes leveraging its new lash technology to create non-toxic, long-wear eyelash extensions that are easy to apply and remove and can last for five to ten days.

“We are continuously evaluating opportunities to acquire leading health and beauty consumer product brands that are accretive and synergistic. Silly George will add approximately $2 million in annualized revenue and represents another step forward in achieving the critical mass and cash flow necessary to reach our goal of profitability,” said Adam Levy, CEO of NEXGEL. “Leveraging our consumer brand platform, there are immediate operational synergies that exist through the combination of our companies including optimization of marketing and overlap in expenses that will drive operating margin expansion. Additionally, Silly George has built a large social media following and consumer database, which includes 88,000 Facebook and 83,000 Instagram followers as well as over 254,000 customer emails, all of which will offer us cross selling opportunities. We welcome Miranda Semmens and her team to NEXGEL.”

Miranda Semmens, CEO of Silly George, stated, “We are proud of the brand that we have built to support the beauty and health of our consumers eyes and lashes. NEXGEL’s focus on skin integrity and overall skincare strongly complements our commitment to high-quality beauty products. Given its strong record of bringing innovative health and beauty products to the forefront of the consumer healthcare industry, we believe NEXGEL is the right partner to bring our business forward in the next stage of our growth.”

NEXGEL has acquired all of the assets of Silly George for $400,000 in cash, $200,000 in NEXGEL common stock, and a 4-year net profit earn out. Under the terms of the agreement, management of Silly George will remain in place and inventory will be provided by the seller at cost and paid for after the sale of each unit.

About NEXGEL, INC.

NEXGEL is a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. NEXGEL brands include Silverseal, Hexagels, Turfguard, Kenkoderm, and Dermablock. Additionally, NEXGEL has strategic contract manufacturing relationships with leading consumer healthcare companies.

Forward-Looking Statement

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words “believe,” “anticipate,” “estimate,” “expect,” “intend,” “plan,” “project,” “prospects,” “outlook,” and similar words or expressions, or future or conditional verbs, such as “will,” “should,” “would,” “may,” and “could,” are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company's actual results, performance, or achievements to be materially different from any anticipated results, performance, or achievements for many reasons. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional risks and uncertainties that could impact the Company's forward-looking statements, please see the Company's Annual Report on Form 10-K for the year ended December 31, 2022, including but not limited to the discussion under “Risk Factors” therein, which the Company filed with the SEC and which may be viewed at http://www.sec.gov/.

Investor Contacts:
Valter Pinto, Managing Director
KCSA Strategic Communications
212.896.1254
valter@kcsa.com


FAQ

What is the recent acquisition by NEXGEL (NASDAQ: NXGL)?

NEXGEL recently acquired Silly George, an international beauty brand specializing in eye and eyelash products.

What is the revenue run rate of Silly George?

Silly George has a revenue run rate of approximately $2 million.

What are the financial terms of the NEXGEL acquisition of Silly George?

NEXGEL acquired Silly George for $400,000 in cash, $200,000 in NEXGEL common stock, and a 4-year net profit earn out.

How will the acquisition of Silly George benefit NEXGEL?

The acquisition is expected to add $2 million in annual revenue, provide operational synergies, and expand cross-selling opportunities through Silly George's customer base and social media following.

Where are Silly George's products sold?

Silly George's products are sold direct-to-consumer and on Amazon in the U.S., U.K., Australia, and the Netherlands.

How does the acquisition impact NEXGEL's marketing strategy?

The acquisition offers immediate operational synergies through marketing optimization and expense overlap.

NexGel, Inc

NASDAQ:NXGL

NXGL Rankings

NXGL Latest News

NXGL Stock Data

16.32M
6.77M
21.73%
2.35%
0.32%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
LANGHORNE